Please login to the form below

Not currently logged in
Email:
Password:

Bayer’s Jean-Luc Lowinski joins Sanofi as senior VP Asia

Based in Shanghai, Lowinski will oversee Sanofi’s operations in the increasingly important Asian market

Jean-Luc Lowinski - SanofiSanofi has appointed Bayer's former global head of animal health Jean-Luc Lowinski to lead its operations in the increasingly important Asian market.

Based in Shanghai as the French pharmaceutical company's senior vice president, Asia region, Lowinski previously held senior roles in a number of Asian countries, serving as head of operations in Singapore, India, Thailand, China and Japan during his time at Bayer.

Following this he was appointed head of Bayer Healthcare, China in 2003 and subsequently became head of Bayer Healthcare, Asia Pacific, and president, Bayer Yakuhin, Japan in 2007.

“I'm confident that his deep knowledge of different Asian cultures makes him ideally suited to lead our operations to continued growth and success in the region,” said Hanspeter Spek, president, global operations at Sanofi.

The pharma company recorded revenues of €2.42bn in Asia last year, up 16.6 per cent on the previous 12 months. In comparison its fortunes in the West dipped, as European sales fell 4 per cent, and its US operations recorded just single digit growth.

This year the company faces an anticipated loss in net income of €1.4bn due to increased generic competition for key products, so building on its Asian performance will be an important part of compensating for lost sales.

6th March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics